Literature DB >> 4022045

Cigarette smoking and the risk of endometrial cancer.

S M Lesko, L Rosenberg, D W Kaufman, S P Helmrich, D R Miller, B Strom, D Schottenfeld, N B Rosenshein, R C Knapp, J Lewis.   

Abstract

Because of evidence of reduced estrogen excretion in the urine of women who smoke cigarettes and evidence linking estrogen levels to the risk of cancer of the female reproductive system, we evaluated the risk of endometrial cancer in relation to cigarette use in a hospital-based case-control study of 510 women with endometrial cancer (cases) and 727 women with other cancers (controls). The rate-ratio estimate (relative risk) for current smokers as compared with women who had never smoked was 0.7 (95 per cent confidence interval, 0.5 to 1.0), and for former smokers the estimate was 0.9 (0.6 to 1.2). For women currently smoking 25 or more cigarettes per day, the rate-ratio estimate was 0.5 (0.3 to 0.8). The effect of current smoking of at least 25 cigarettes per day appeared to be confined to postmenopausal women, among whom the estimate was 0.5 (0.2 to 0.9). Among premenopausal women the estimate was 0.9 (0.4 to 2.2), but the difference between these two estimates could have been due to chance. The data suggest that women who smoke heavily may have a lower risk of endometrial cancer than nonsmokers. The present findings do not have direct public health importance since cigarettes, overall, have serious deleterious effects. However, if these results are confirmed, elucidation of the underlying mechanisms whereby smoking reduces the risk would be of interest and might be useful in the development of strategies for preventing endometrial cancer.

Entities:  

Keywords:  Behavior; Cancer; Control Groups; Data Analysis; Data Collection; Diseases; Endometrial Cancer; Menopause; Neoplasms; Population At Risk; Reproduction; Research Methodology; Smoking; Social Behavior

Mesh:

Year:  1985        PMID: 4022045     DOI: 10.1056/NEJM198509053131001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Risk factors for self-reported uterine fibroids: a case-control study.

Authors:  A R Samadi; N C Lee; W D Flanders; J R Boring; E B Parris
Journal:  Am J Public Health       Date:  1996-06       Impact factor: 9.308

2.  Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

Authors: 
Journal:  Breast Cancer Res Treat       Date:  2007-10-31       Impact factor: 4.872

3.  Cigarette smoking, steroid hormones, and bone mineral density in young women.

Authors:  M Daniel; A D Martin; D T Drinkwater
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells.

Authors:  D C Spink; D W Lincoln; H W Dickerman; J F Gierthy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Bone mineral density, sex steroids, and mineral metabolism in premenopausal smokers.

Authors:  N Ortego-Centeno; M Muñoz-Torres; J Hernandez-Quero; A Jurado-Duce; J de la Higuera Torres-Puchol
Journal:  Calcif Tissue Int       Date:  1994-12       Impact factor: 4.333

Review 6.  Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine.

Authors:  H Remmer
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

7.  Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity.

Authors:  Ashley S Felix; Hannah P Yang; Gretchen L Gierach; Yikyung Park; Louise A Brinton
Journal:  Cancer Causes Control       Date:  2014-02-01       Impact factor: 2.506

8.  Publication visibility of sensitive public health data: when scientists bury their results.

Authors:  David A Rier
Journal:  Sci Eng Ethics       Date:  2004-10       Impact factor: 3.525

9.  Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.

Authors:  Ophira Ginsburg; Parviz Ghadirian; Jan Lubinski; Cezary Cybulski; Henry Lynch; Susan Neuhausen; Charmaine Kim-Sing; Mark Robson; Susan Domchek; Claudine Isaacs; Jan Klijn; Susan Armel; William D Foulkes; Nadine Tung; Pal Moller; Ping Sun; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2008-05-16       Impact factor: 4.872

10.  Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.

Authors:  R L Barbieri; J Gochberg; K J Ryan
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.